Impact of Thyroid Treatment on Ovarian Function and Pregnancy Outcomes in Women with Differentiated Thyroid Cancer

ConditionThyroid Gland
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age20-45
SponsorZhejiang Provincial People's Hospital

About this trial

This project aims to study the effects of different types of thyroid surgery and RAIT on ovarian function and pregnancy outcomes of DTC women of childbearing age, analyze possible risk factors, and assess whether potential risk factors such as age, thyroid stimulating hormone (TSH) levels and positive thyroid antibodies are related to ovarian hypofunction and adverse pregnancy outcomes.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Age 20-45 years old;

Premenopausal women whose thyroid B-ultrasound + surgical pathology is clearly differentiated thyroid cancer (papillar thyroid cancer or follicular thyroid cancer);

TNM stage is in stage I (T1-3, N0 or N1, M0);

Treatment of thyroid tumor resection: unilateral lobe of the thyroid + isthmus resection, total thyroidectomy, total thyroidectomy + RAIT.

Disqualifiers

Patients with malignant tumors in other parts or low undifferentiated thyroid cancer;

Patients with abnormal liver and kidney function;

TNM stage II and above;

History of ovarian surgery, hysterectomy, pelvic surgery or radiation therapy;

Trial design

Design model

Parallel

Treatments tested in this trial

  • Total thyroidectomy

    Procedure/Surgery

    Total thyroidectomy

  • Total thyroidectomy + RAIT

    Procedure/Surgery

    Total thyroidectomy + RAIT

  • Thyroid one-sided lobe + isthmus resection

    Procedure/Surgery

    Thyroid one-sided lobe + isthmus resection

Treatment groups

300 Participants
are divided into 3 treatment groups
Group A: Thyroid one-sided lobe + isthmus resectionExperimental treatment 1 intervention
Group B: Total thyroidectomyExperimental treatment 1 intervention
Group C: Total thyroidectomy + RAITExperimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

AMH level

Measure the concentration of AMH in serum

Time frame
before treatment and 3, 6, 12 and 24 months after treatment

Secondary outcomes

1

Thyroid function

Measure the level of TSH、T3、T4、FT3、FT4、TGAB、TPOAB in serum

Time frame
before tratment and 3, 6, 12 and 24 months after treatment
2

clinical pregnancy rate

Clinical pregnancy is defined as the detection of intrauterine gestational sac through ultrasound, and the clinical pregnancy rate is calculated by clinically pregnant women/total women.

Time frame
up to 24 months after the treatment

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: